{"componentChunkName":"component---node-modules-gatsby-theme-buzzing-src-gatsby-theme-blog-core-templates-post-query-js","path":"/en/reddit/r/investing/comments/o8fs8u/ntla_and_regn_announce_that_they_have/","result":{"data":{"site":{"siteMetadata":{"title":"国外股市热门","author":"Buzzing.cc","description":"用中文浏览国外股票社区里的热门讨论","keywords":["buzzing","美股","股票","股市"],"siteUrl":"https://stocks.buzzing.cc","telegram":"@stocks_top","iconUrl":"https://stocks.buzzing.cc/avatar.png","defaultSocialImageUrl":null,"social":[{"name":"Reddit Stocks","url":"https://www.reddit.com/r/stocks","external":true},{"name":"Reddit Investing","url":"https://www.reddit.com/r/investing","external":true},{"name":"Charlie Bilello's twitter","url":"https://twitter.com/charliebilello","external":true},{"name":"Buzzing","url":"https://www.buzzing.cc/","external":true}],"menuLinks":[{"name":"每周精选","url":"/issues","external":null}],"disqus":null,"utterances":null,"localize":[{"title":"Buzzing on Stocks","description":"See popular discussions in foreign stock communities in your native language","keywords":["buzzing","stocks","U.S. stocks"],"locale":"en","social":{"name":null,"url":null,"external":null},"menuLinks":[{"name":"Weekly Selection","url":"/en/issues","external":null}]},{"title":"國外股市熱門","description":"用中文瀏覽國外股票社區裡的熱門討論","keywords":["buzzing","美股","股票","股市"],"locale":"zh-Hant","social":null,"menuLinks":[{"name":"每週精選","url":"/zh-Hant/issues","external":null}]},{"title":"米国株式市場人気の話し合います","description":"人気の米国株式市場の話し合いまを日本語で閲覧","keywords":["buzzing","米国株式市場"],"locale":"ja","social":null,"menuLinks":[]}]}},"blogPost":{"id":"RedditPost-730adac2-48b9-5aaa-ad04-6f3762247e33","excerpt":"Big news in the medical field today as Intellia Therapeutics and Regeneron\nannounce, for the first time, history-making news that they have successfully\ntreated a genetic disease, ATTR amyloidosis, with a single infusion of CRISPR, a\nprogrammable gene editing tool. This data was also published in…","body":"<!-- SC_OFF --><div class=\"md\"><p>Big news in the medical field today as Intellia Therapeutics and Regeneron announce, for the first time, history-making news that they have successfully treated a genetic disease, ATTR amyloidosis, with a single infusion of CRISPR, a programmable gene editing tool. This data was also published in the premiere medical journal, NEJM</p>\n\n<p><a href=\"https://ir.intelliatx.com/news-releases/news-release-details/intellia-and-regeneron-announce-landmark-clinical-data-showing\">https://ir.intelliatx.com/news-releases/news-release-details/intellia-and-regeneron-announce-landmark-clinical-data-showing</a></p>\n\n<p><a href=\"https://www.nejm.org/doi/full/10.1056/NEJMoa2107454?query=featured_home\">https://www.nejm.org/doi/full/10.1056/NEJMoa2107454?query=featured_home</a></p>\n\n<p>For those unaware, CRISPR is a programmable gene editing system discovered in 2012 which allows precise gene editing at a target locus. Jennifer Doudna, the founder of NTLA, and Emannuelle Charpentier, the founder of CRSP, were awarded the 2020 Nobel Prize in Chemistry.</p>\n\n<p>This really demonstrates the promise of CRISPR to treat all genetic diseases. </p>\n\n<p>I believe this will cause the entire sector of gene editing and maybe genomics stocks to move higher. Other stocks in this field include BEAM, EDIT, VERV, VRTX, and CRSP.</p>\n\n<p>Some additional articles:</p>\n\n<p><a href=\"https://www.npr.org/sections/health-shots/2021/06/26/1009817539/he-inherited-a-devastating-disease-a-crispr-gene-editing-breakthrough-stopped-it?fbclid=IwAR0pufLeRHs8QGStWirHjLpAyw0WF8wVnOZ-oRuHPu520tGZ4J2Scmwpxd4\">https://www.npr.org/sections/health-shots/2021/06/26/1009817539/he-inherited-a-devastating-disease-a-crispr-gene-editing-breakthrough-stopped-it?fbclid=IwAR0pufLeRHs8QGStWirHjLpAyw0WF8wVnOZ-oRuHPu520tGZ4J2Scmwpxd4</a></p>\n\n<p><a href=\"https://www.sciencemag.org/news/2021/06/crispr-injected-blood-treats-genetic-disease-first-time\">https://www.sciencemag.org/news/2021/06/crispr-injected-blood-treats-genetic-disease-first-time</a></p>\n\n<p><a href=\"https://www.statnews.com/2021/06/26/intellia-therapeutics-ntla-2001-data/\">https://www.statnews.com/2021/06/26/intellia-therapeutics-ntla-2001-data/</a></p>\n</div><!-- SC_ON -->","slug":"/reddit/r/investing/comments/o8fs8u/ntla_and_regn_announce_that_they_have/","title":"$NTLA and $REGN announce that they have successfully corrected a hereditary disease with an infusion of CRISPR","tags":["investing","reddit"],"date":"June 27, 2021","dateISO":"2021-06-27T05:53:50.000Z","datetime":"2021-06-27 05:53","image":null,"imageAlt":null,"socialImage":null,"__typename":"SocialMediaPost","thirdPartyId":"730adac2-48b9-5aaa-ad04-6f3762247e33","provider":"Reddit","url":"https://www.reddit.com/r/investing/comments/o8fs8u/ntla_and_regn_announce_that_they_have/","originalUrl":"https://www.reddit.com/r/investing/comments/o8fs8u/ntla_and_regn_announce_that_they_have/","imageRemote":null,"video":null,"channel":"investing","channelUrl":"https://www.reddit.com/r/investing","author":"Social_History","authorUrl":"https://www.reddit.com/user/Social_History","authorImage":null,"authorImageRemote":null,"authorSlug":"Social_History","score":87,"views":null,"sharedCount":null,"likeCount":null,"sharedContent":null,"parent":{"localize":[{"title":"$NTLAと$REGNがCRISPRの注入で遺伝性疾患の改善に成功したと発表","the_new_excerpt":"Intellia Therapeutics社とRegeneron社が本日、医療分野でのビッグニュースを発表しました。\n遺伝性疾患の治療に成功したという、歴史的なニュースが発表されました。\n遺伝病であるATTRアミロイドーシスを、プログラム可能な遺伝子編集ツールであるCRISPRを1回の注入で治療することに成功したと発表しました。\n遺伝病であるATTRアミロイドーシスの治療に成功したことを発表しました。また、このデータは...","locale":"ja"},{"title":"$NTLA和$REGN宣布，他们已经成功地用CRISPR输液纠正了一种遗传性疾病","the_new_excerpt":"今天医学领域的重大新闻是Intellia Therapeutics公司和Regeneron公司\n首次宣布了一个创造历史的消息，即他们已经成功地\n他们首次成功地用CRISPR这一可编程的基因编辑工具治疗了一种遗传性疾病--ATTR淀粉样变性。\n可编程基因编辑工具。这一数据也被发表在...","locale":"zh"},{"title":"$NTLA和$REGN宣佈，他們已經成功地用CRISPR輸液糾正了一種遺傳性疾病","the_new_excerpt":"今天醫學領域的重大新聞是Intellia Therapeutics公司和Regeneron公司\n首次宣佈了一個創造歷史的消息，即他們已經成功地\n他們首次成功地用CRISPR這一可編程的基因編輯工具治療了一種遺傳性疾病--ATTR澱粉樣變性。\n可編程基因編輯工具。這一數據也被髮表在...","locale":"zh-Hant"}]}},"previous":{"id":"RedditPost-3a20f912-25b9-5efc-b73f-037cb43ea0af","excerpt":"","slug":"/reddit/r/wallstreetbets/comments/o8ki2x/the_definitive_guide_to_buying_fds/","title":"The Definitive Guide to Buying FDs.","date":"June 27, 2021","__typename":"SocialMediaPost","provider":"Reddit","parent":{"localize":[{"title":"FD購入の決定版。","the_new_excerpt":null,"locale":"ja"},{"title":"购买FDs的权威指南。","the_new_excerpt":null,"locale":"zh"},{"title":"購買FDs的權威指南。","the_new_excerpt":null,"locale":"zh-Hant"}]}},"next":{"id":"RedditPost-7480a954-8cd0-5c42-8fe0-1037c293072e","excerpt":"Lawmakers announced Friday an investigation into the approval and pricing of\nBiogen Inc's Alzheimer's drug, Aduhelm, amid concerns over its steep price and\ndoubts if the clinical evidence proves the drug works. Three of the 11 members\nof FDA's independent advisory panel have resigned in protest over…","slug":"/reddit/r/stocks/comments/o8drza/congress_to_probe_approval_pricing_of_biogens/","title":"Congress to Probe Approval, Pricing of Biogen's Alzheimer's Drug","__typename":"SocialMediaPost","date":"June 27, 2021","provider":"Reddit","parent":{"localize":[{"title":"バイオジェン社のアルツハイマー型認知症治療薬の承認と価格を米国議会が調査","the_new_excerpt":"議員たちは金曜日、バイオジェン社のアルツハイマー病治療薬「アドゥヘルム」の承認と価格設定に関する調査を発表しました。\nバイオジェン社のアルツハイマー病治療薬「アドゥヘルム」の承認と価格について調査することを発表しました。\nバイオジェン社のアルツハイマー型認知症治療薬「アデュエルム」は、価格の高さや、薬の効果を証明する臨床的証拠があるのかどうか疑問視されている。11人のメンバーのうち3人は\nFDA（米国食品医薬品局）の独立諮問委員会のメンバー11名のうち3名が、この問題に抗議して辞任しました。","locale":"ja"},{"title":"美国国会将调查百健公司阿尔茨海默病药物的批准和定价问题","the_new_excerpt":"立法者周五宣布对百健公司的阿尔茨海默病药物Aduhelm的批准和定价进行调查。\n百健公司的阿尔茨海默氏症药物Aduhelm，因为人们对其昂贵的价格和临床证据是否有效表示担忧。\n怀疑临床证据是否证明该药物有效。11名成员中的3名\n美国食品和药物管理局独立咨询小组的三名成员已经辞职，以示抗议。","locale":"zh"},{"title":"美國國會將調查百健公司阿爾茨海默病藥物的批准和定價問題","the_new_excerpt":"立法者週五宣佈對百健公司的阿爾茨海默病藥物Aduhelm的批准和定價進行調查。\n百健公司的阿爾茨海默氏症藥物Aduhelm，因爲人們對其昂貴的價格和臨牀證據是否有效表示擔憂。\n懷疑臨牀證據是否證明該藥物有效。11名成員中的3名\n美國食品和藥物管理局獨立諮詢小組的三名成員已經辭職，以示抗議。","locale":"zh-Hant"}]}}},"pageContext":{"basePath":"/","pageType":"detail","id":"RedditPost-730adac2-48b9-5aaa-ad04-6f3762247e33","previousId":"RedditPost-3a20f912-25b9-5efc-b73f-037cb43ea0af","nextId":"RedditPost-7480a954-8cd0-5c42-8fe0-1037c293072e","maxWidth":1024,"siteMetadata":null,"locale":"en","hrefLang":"en-US","originalPath":"/reddit/r/investing/comments/o8fs8u/ntla_and_regn_announce_that_they_have/","dateFormat":"MM/DD/YYYY"}},"staticQueryHashes":["1239077767","2744905544","3280999885"]}